GSA Capital Partners’s Atossa Therapeutics ATOS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,717	Closed	-$269K	–	1669
2025 Q3	$269K	Buy	20,717 +17,315	+509%	+$214K	0.02%	1261
2025 Q2	$42K	Buy	+3,402	New	+$40.7K	﹤0.01%	1668
2024 Q1	–	Sell	-29,939	Closed	-$395K	–	1594
2023 Q4	$395K	Buy	29,939 +6,780	+29%	+$73.1K	0.03%	954
2023 Q3	$256K	Buy	23,159 +2,985	+15%	+$43.3K	0.02%	1165
2023 Q2	$381K	Buy	+20,174	New	+$245K	0.04%	907
2022 Q4	–	Sell	-4,793	Closed	-$60K	–	1454
2022 Q3	$60K	Buy	+4,793	New	+$69.6K	0.01%	1409
2022 Q2	–	Sell	-4,415	Closed	-$83K	–	1390
2022 Q1	$83K	Buy	+4,415	New	+$89.7K	0.01%	1311
2021 Q2	–	Sell	-1,528	Closed	-$48K	–	1310
2021 Q1	$48K	Buy	+1,528	New	+$55.8K	0.01%	1031